互联网 123renren.net
赏析网:首页 > 医药医学 > 《临床肿瘤学医学期刊》 > 2006年第02期
临床肿瘤学医学期刊2006年第02期封面 购买


phase i and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function
cefixime allows greater dose escalation of oral irinotecan: a phase i study in pediatric patients with refractory solid tumors
randomized study of the arbeitsgemeinschaft gynaekologische onkologie ovarian cancer study group comparing quality of life in patients with ovarian cancer treated w..
phase iii trial of intraperitoneal therapy with yttrium-90
randomized double-blind trial of estrogen replacement therapy versus placebo in stage i or ii endometrial cancer: a gynecologic oncology group study
single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm
fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at in..
combined-modality therapy versus radiotherapy alone for treatment of early-stage hodgkin's disease: cure balanced against complications
extranodal natural killer t-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study
phase ii study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: ..
results of the national initiative for cancer care quality: how can we improve the quality of cancer care in the united states
impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial
outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports
randomized phase ii study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: radiation therapy oncology group trial 0012
increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase i trial results
multicenter phase ii trial of s-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma
neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging
tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status
adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non
randomized phase ii trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage iiib/iv non
prognostic value of international neuroblastoma pathology classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localize..
sharing brca1/2 test results with first-degree relatives: factors predicting who women tell
optimal selection of individuals for brca mutation testing: a comparison of available methods
endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in..
molecular classification identifies a subset of human papillomavirus
association of activated transcription factor nuclear factor b with chemoradiation resistance and poor outcome in esophageal carcinoma
preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma
antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer
antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer
defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
baalc expression and flt3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications
serum ykl-40 predicts relapse-free and overall survival in patients with american joint committee on cancer stage i and ii melanoma
subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry
randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care
identification in administrative databases of women dying of breast cancer
characterization of brca1 and brca2 mutations in a large united states sample
community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000
analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of cancer and leukemia group b trial 80001
white matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function
stability of parental understanding of random assignment in childhood leukemia trials: an empirical examination of informed consent
randomized phase ii study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma
racial differences in trust and lung cancer patients' perceptions of physician communication
relationship between cisplatin administration and the development of ototoxicity
quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal wo..
anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study
standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase iii us intergroup trial s9321
phase i/ii trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma
osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors
characteristics and outcome of diffuse large b-cell lymphoma in hepatitis c virus
bcl2 expression is a prognostic marker for the activated b-cell
additional genetic high-risk features such as 11q deletion, 17p deletion, and v3-21 usage characterize discordance of zap-70 and vh mutation status in chronic lymph..
descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma
elevated serum b-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders
购买 收藏 投稿
关于我们 | 网站声明 | 刊社管理 | 网站地图 | 联系方式 | 中图分类法 | RSS 2.0订阅 | IP查询
全刊赏析网 2018